Tag Archives: FDG/PET

FDG/PET Best for Mesothelioma Diagnosis and Prognosis

PET Scan

When it comes to diagnosing mesothelioma and predicting patient prognosis, Positron Emission Tomography (PET) using a radioactive tracer may be the most effective imaging modality. That’s the finding of a new study out of Japan. Mesothelioma is a fast-growing cancer that starts on the mesothelial membranes which line the chest cavity or wrap around the lungs and heart. It is caused by past exposure to asbestos, most often in an industrial setting. The greater the level of exposure, the greater the likelihood that mesothelioma will occur. Because it is highly resistant to conventional treatments, early diagnosis is critical. Unfortunately, mesothelioma can also be challenging to diagnose. If patient history and symptoms suggest mesothelioma, imaging modalities like computed tomography (CT) and X-rays can … Continue reading FDG/PET Best for Mesothelioma Diagnosis and Prognosis »

Mesothelioma Prognosis Accuracy Improves with PET/CT ‘Delayed Phase’

Detecting Mesothelioma with New CT Algorithm

More research has confirmed the value of FDG-PET/CT technology for predicting treatment response in mesothelioma – especially when the scan is conducted in two phases. Positron emission tomography (PET) is a nuclear medicine imaging technique that produces three-dimensional images of functional processes in the body.  When the molecule FDG (fluorodeoxyglucose, a type of sugar) is used as the tracer, PET allows doctors to ‘see’ metabolic processes as they are happening.  Because metabolism is often higher in cancer cells, FDG-PET has proven to be a useful tool for diagnosing mesothelioma, the asbestos-linked cancer.   When FDG-PET is combined with computed tomography (CT), another powerful imaging test, the resulting images contain even more potentially crucial diagnostic, staging and prognostic information for mesothelioma. Now, a study conducted in Japan … Continue reading Mesothelioma Prognosis Accuracy Improves with PET/CT ‘Delayed Phase’ »